The Beta-2-Microglobulin (B2M) Serum Test measures the levels of beta-2-microglobulin, a protein found on the surface of most cells, particularly white blood cells. This test is used to monitor kidney function and immune system activity and is helpful in diagnosing and evaluating the progression of certain cancers like multiple myeloma and lymphoma. Elevated levels of beta-2-microglobulin in the blood can indicate kidney disease, immune disorders, or malignancies, providing valuable information for treatment and management.

Elevated beta-2-microglobulin levels are often associated with kidney dysfunction, immune system disorders, and certain cancers. This test is essential for individuals undergoing cancer treatment or those at risk of kidney disease, as it helps monitor disease progression and treatment effectiveness. For patients with multiple myeloma, lymphoma, or other immune-related conditions, regular B2M testing aids in assessing response to therapy and overall prognosis, supporting early intervention if levels rise unexpectedly.

Test price for other cities